| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
251,510,000 |
| Market
Cap: |
132.94(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$414.13 - $539.68 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 17 |
| Guru Rank Value : 22.1 |
| Guru Occurances : 4 |
|
|
|
|
|
| |
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
45,506 |
52,053 |
52,427 |
77,577 |
| Total Sell Value |
$23,439,266 |
$26,598,808 |
$26,775,666 |
$38,325,083 |
| Total People Sold |
5 |
6 |
7 |
8 |
| Total Sell Transactions |
6 |
8 |
10 |
15 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Stark Leah |
EVP & CHRO |
• – – |
2021-03-02 |
4 |
D |
$311.66 |
$222,837 |
D/D |
(715) |
12,885 |
|
- |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2021-03-02 |
4 |
D |
$311.66 |
$153,337 |
D/D |
(492) |
43,951 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• – – |
2021-03-02 |
4 |
D |
$311.66 |
$167,050 |
D/D |
(536) |
55,624 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2021-03-02 |
4 |
D |
$311.66 |
$150,532 |
D/D |
(483) |
54,320 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,895 |
5,314 |
|
- |
|
| Penczek Ronald W |
SVP, Chief Accounting Officer |
• – – |
2021-03-01 |
4 |
D |
$311.48 |
$254,791 |
D/D |
(818) |
2,419 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
83,835 |
101,944 |
|
- |
|
| Boudreaux Gail |
President and CEO |
• • – |
2021-03-01 |
4 |
D |
$311.48 |
$11,077,475 |
D/D |
(35,564) |
18,109 |
|
- |
|
| Patel Prakash R |
EVP & President, DBG |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,866 |
21,288 |
|
- |
|
| Patel Prakash R |
EVP & President, DBG |
• – – |
2021-03-01 |
4 |
D |
$311.48 |
$57,935 |
D/D |
(186) |
11,422 |
|
- |
|
| Todt Blair Williams |
EVP and Chief Legal Officer |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,007 |
2,804 |
|
- |
|
| Norwood Felicia F |
EVP & President, GBD |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,641 |
30,849 |
|
- |
|
| Norwood Felicia F |
EVP & President, GBD |
• – – |
2021-03-01 |
4 |
D |
$311.48 |
$68,526 |
D/D |
(220) |
16,208 |
|
- |
|
| Stark Leah |
EVP & CHRO |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,806 |
13,600 |
|
- |
|
| Stark Leah |
EVP & CHRO |
• – – |
2021-03-01 |
4 |
D |
$311.48 |
$49,214 |
D/D |
(158) |
11,794 |
|
- |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,032 |
44,443 |
|
- |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2021-03-01 |
4 |
D |
$311.48 |
$4,432,672 |
D/D |
(14,231) |
18,411 |
|
- |
|
| Alter Jeffrey D. |
EVP, IngenioRx & Anthem Health |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,649 |
5,395 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,032 |
56,160 |
|
- |
|
| Mccarthy Gloria M |
EVP & Chief Administrative Off |
• – – |
2021-03-01 |
4 |
D |
$311.48 |
$3,728,727 |
D/D |
(11,971) |
30,128 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,232 |
54,803 |
|
- |
|
| Gallina John E |
EVP & Chief Financial Officer |
• – – |
2021-03-01 |
4 |
D |
$311.48 |
$3,311,967 |
D/D |
(10,633) |
28,571 |
|
- |
|
| Schneider Ryan M. |
Director |
– • – |
2021-02-04 |
4 |
B |
$296.03 |
$503,251 |
D/D |
1,700 |
2,921 |
2.39 |
29% |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2020-12-15 |
4 |
AS |
$312.01 |
$1,822,972 |
D/D |
(5,833) |
32,642 |
|
20% |
|
| Haytaian Peter D |
EVP & President, Commercial |
• – – |
2020-12-15 |
4 |
OE |
$146.93 |
$857,043 |
D/D |
5,833 |
38,475 |
|
- |
|
1940 Records found
|
|
Page 7 of 78 |
|
|
5.40 (1.01%) 
